Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD

17Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To investigate whether there are significant differences in efficacy between nebulisers compared to pMDI or DPI currently used for bronchodilator therapy in exacerbations of COPD.

Cite

CITATION STYLE

APA

van Geffen, W. H., Douma, W. R., Slebos, D. J., & Kerstjens, H. A. M. (2015). Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. Cochrane Database of Systematic Reviews, 2015(8). https://doi.org/10.1002/14651858.CD011826

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free